Differential effects of prostaglandin E2-sensitive receptors on contractility of human ocular cells that regulate conventional outflow

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 7, 2013, Pages 4782-4790

  Wang, Jenny W ^a   Woodward, David F ^a   Stamer, W Daniel ^b  

^a ALLERGAN INC   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell impedance; Conventional outflow; Prostaglandin E2 receptors; Schlemm's canal; Trabecular meshwork

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; 8 CHLORO N2 [3 (FURFURYLTHIO) PROPIONYL] DIBENZ [B, F] [1, 4] OXAZEPINE 10 (11H) CARBOHYDRAZIDE; BUTAPROST; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; RHO KINASE; SULPROSTONE; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAOCULAR PRESSURE; MICROSCOPY; NERVE CELL MEMBRANE CONDUCTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIGIDITY; SCHLEMM CANAL; TRABECULAR MESHWORK;

CELL IMPEDANCE; CONVENTIONAL OUTFLOW; PROSTAGLANDIN E2 RECEPTORS; SCHLEMM'S CANAL; TRABECULAR MESHWORK;

AMIDES; CELLS, CULTURED; DINOPROSTONE; ELASTICITY; ENZYME INHIBITORS; HUMANS; POLYMERASE CHAIN REACTION; PYRIDINES; RECEPTORS, PROSTAGLANDIN; TRABECULAR MESHWORK;

EID: 84880278555     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12363     Document Type: Article

References (36)

1. Kaufman PL, Alm A, Adler FH. Adler's Physiology of the Eye: Clinical Application. 10th ed. St. Louis: Mosby, Inc.; 2003.
2. Johnson M. 'What controls aqueous humour outflow resistance?' Exp Eye Res. 2006;82:545-557.
3. Millard LH, Woodward DF, Stamer WD. The role of the prostaglandin EP4 receptor in the regulation of human outflow facility. Invest Ophthalmol Visual Sci. 2011;52: 3506-3513.
4. Stamer WD, Piwnica D, Jolas T, et al. Cellular basis for bimatoprost effects on human conventional outflow. Invest Ophthalmol Vis Sci. 2010;51:5176-5181.
5. Christiansen GA, Nau CB, McLaren JW, Johnson DH. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology. 2004;111:1658-1662.
6. Toris CB, Zhan G, Fan S, et al. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. J Glaucoma. 2007;16:189-195.
7. Bahler CK, Howell KG, Hann CR, Fautsch MP, Johnson DH. Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments. Am J Ophthalmol. 2008;145:114-119.
8. Wan Z, Woodward DF, Cornell CL, et al. Bimatoprost, prostamide activity, and conventional drainage. Invest Ophthalmol Vis Sci. 2007;48:4107-4115.
9. Woodward DF, Nilsson SF, Toris CB, Kharlamb AB, Nieves AL, Krauss AH. Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow. Invest Ophthalmol Vis Sci. 2009; 50:3320-3328.
10. Boussommier-Calleja A, Bertrand J, Woodward DF, Ethier CR, Stamer WD, Overby DR. Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. Invest Ophthalmol Vis Sci. 2012;53:5838-5845.
11. Nilsson SF, Drecoll E, Lutjen-Drecoll E, et al. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 2006; 47:4042-4049.
12. Rao PV, Deng PF, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
13. Zhou EH, Krishnan R, Stamer WD, et al. Mechanical responsiveness of the endothelial cell of Schlemm's canal: scope, variability and its potential role in controlling aqueous humour outflow. J R Soc Interface. 2012;9:1144-1155.
14. Lu Z, Overby DR, Scott PA, Freddo TF, Gong H. The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes. Exp Eye Res. 2008; 86:271-281.
15. Tian B, Kaufman PL. Effects of the Rho kinase inhibitor Y- 27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res. 2005;80:215-225.
16. Honjo M, Tanihara H, Inatani M, et al. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137-144.
17. Singh I, Knezevic N, Ahmmed GU, Kini V, Malik AB, Mehta D. Galphaq-TRPC6-mediated Ca2{thorn}entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem. 2007;282:7833-7843.
18. Kumar J, Epstein DL. Rho GTPase-mediated cytoskeletal organization in Schlemm's canal cells play a critical role in the regulation of aqueous humor outflow facility. J Cell Biochem. 2011;112:600-606.
19. Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 2004;45:2263-2271.
20. Rao PV, Deng P, Sasaki Y, Epstein DL. Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res. 2005;80: 197-206.
21. Chudgar SM, Deng P, Maddala R, Epstein DL, Rao PV. Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway. Mol Vis. 2006;12:1117-1126.
22. Stamer WD, Roberts BC, Howell DN, Epstein DL. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
23. Stamer WD, Seftor RE, Snyder RW, Regan JW. Cultured human trabecular meshwork cells express aquaporin-1 water channels. Curr Eye Res. 1995;14:1095-1100.
24. Abramovitz M, Adam M, Boie Y, et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta. 2000;1483:285-293.
25. af Forselles KJ, Root J, Clarke T, et al. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist. Br J Pharmacol. 2011;164:1847-1856.
26. O'Connell M, Zeller W, Burgeson J, et al. Peri-substituted hexahydro-indolones as novel, potent and selective human EP3 receptor antagonists. Bioorg Med Chem Lett. 2009;19: 778-782.
27. Billot X, Chateauneuf A, Chauret N, et al. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg Med Chem Lett. 2003;13:1129-1132.
28. Wilson RJ, Giblin GM, Roomans S, et al. GW627368X ((N-{2-[4- (4, 9-diethoxy-1-oxo-1, 3-dihydro-2H-benzo[f]isoindol-2-yl)- phenyl] acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. Br J Pharmacol. 2006;148:326-339.
29. Poloso NJ, Urquhart P, Nicolaou A, Wang J, Woodward DF. PGE(2) differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP(2)/ EP(4)). Mol Immunol. 2013;54:284-295.
30. Wilson SJ, Roche AM, Kostetskaia E, Smyth EM. Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem. 2004;279:53036-53047.
31. Liang Y, Woodward DF, Guzman VM, et al. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br J Pharmacol. 2008;154:1079-1093.
32. Prinster SC, Hague C, Hall RA. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev. 2005;57:289-298.
33. Hoyng PF, de Jong N. Iloprost, a stable prostacyclin analog, reduces intraocular pressure. Invest Ophthalmol Vis Sci. 1987; 28:470-476.
34. Krauss AH, Woodward DF, Chen J, et al. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties. J Ocul Pharmacol Ther. 1995;11:203-212.
35. Gabelt BT, Hennes EA, Bendel MA, Constant CE, Okka M, Kaufman PL. Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys. J Ocul Pharmacol Ther. 2009;25:1-8.
36. Johnson MC, Kamm RD. The role of Schlemm's canal in aqueous outflow from the human eye. Invest Ophthalmol Vis Sci. 1983;24:320-325.